Page 1 of 4
Ordinary General Assembly’s Meeting Agenda
Item (1): Approval on the report of the Board of Directors for the fiscal year ending on 31/12/2020.
Item (2): Approval on the company's auditors' report for the fiscal year ending on 31/12/2020.
Item (3): Approval on the financial statements for the fiscal year ending on 31/12/2020.
Item (4): Approval to absolve the Board of Directors members liability during the year ended 31/12/2020 . Item (5): Approval of the formation of the audit committee, specifying its tasks, work controls, and remuneration for its members for the new session, which starts from the assembly on 30/05/2021 and ends on 07/01/2024 AD, and the candidates are as follows:
1. Mr. / Khalid Abid Qama - Chairman.
2. Mr. / Ali Al-Azhari – Member.
3. Mr. / Kinana Al Ghaleb Al Sharif – Member.
Item (6): Approval on the business and contracts concluded between the company and the company of Dr.
Suleiman Abdel Qader Fakeeh Hospital and for which as a member of the Board of Directors, Dr. Mazen Suleiman Abdel Qadir Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year in the amount of 16,330,548 SR and this agreement does not have any preferential conditions.
Item (7): Approval on business and contracts concluded between the company and the company of Dr. Suleiman Abdel Qader Fakeeh for Medical Education and for which a member of the Board of Directors Dr. Mazen Suleiman Abdel Qader Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 895,798SR. This agreement does not have any preferential terms.
Item (8): Approval on business and contracts concluded between the company and Al-Farabi Distinguished Health Care Company, in which a member of the Board of Directors Dr. Mazen Suleiman Abdul Qadir Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for
1,885,965SR. This agreement has no preferential terms.
Item (9): Approval on the business and contracts concluded between the company and the Arab Kameed Company Ltd., in which a member of the Board of Directors Dr. Mazen Suleiman Abdel Qadir Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 151,236 SR This agreement has no preferential terms.
Item (10): Voting on the business and contracts concluded between the company and the company of Dr.
Suleiman Fakeeh Center, in which a member of the Board of Directors, Dr. Mazen Suleiman Abdul Qadir Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 641,943SR, this agreement has no preferential terms.
Item (11): Approval on the business and contracts concluded between the company and Dr. Mazen Suleiman Fakeeh Integrated Medical Company Limited, for which a member of the Board of Directors Dr. Mazen Suleiman Abdul Qadir Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a period of one year for 497,444SR. This agreement has no preferential terms.
Page 2 of 4
Item (12): Approval on the business and contracts concluded between the company and Fakeeh Optical Limited Company, for which a member of the Board of Directors Dr. Mazen Suleiman Abdul Qadir Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a period of one year for
4,501SR. This agreement has no preferential terms.
Item (13): Approval on the business and contracts concluded between the company and Dr. Suleiman Fakeeh Hospital and for which as a member of the Board of Directors, Dr. Mazen Suleiman Abdel Qadir Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year in the amount of 245,916SR and this agreement does not have any preferential conditions.
Item (14): Approval on the business and contracts concluded between the company and Dr. Suleiman Fakeeh Hospital and for which as a member of the Board of Directors, Dr. Mazen Suleiman Abdel Qadir Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year in the amount of 23,59SR and this agreement does not have any preferential conditions.
Item (15): Approval on business and contracts concluded between the company and Khalid Ahmed Al-Juffali Construction Company Limited and for which a member of the Board of Directors Mrs. Al-Dana Khalid Al-Juffali has an indirect interest in it which is a medical insurance contract for the company’s employees for a year for 136,051 SR. This agreement has no preferential terms.
Item (16): Approval on business and contracts concluded between the company and Gap Corp Saudi Arabia Ltd.
in which a member of the Board of Directors Mrs. Dana Khalid Al-Juffali has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 190,179 SR. This agreement has no preferential terms.
Item (17): Approval on business and contracts concluded between the company and Khalid Ahmed Al-Juffali Company and for which a member of the Board of Directors Mrs. Al-Dana Khalid Al-Juffali has an indirect interest in it which is a medical insurance contract for the company’s employees for a year for 176,359SR. This agreement has no Preferential terms.
Item (18): Approval on business and contracts concluded between the company and Lonsdale and Associates Insurance Brokerage Company, for which a member of the Board of Directors Mrs. Dana Khalid Al-Juffali has an indirect interest in it which is a medical insurance contract for the company’s employees for a year for 242,446 SR. This agreement has no preferential terms.
Item (19): Approval on the business and contracts that will take place between the company and Khalid Ahmed Al-Juffali Energy and Utilities Company Limited and for which a member of the Board of Directors Mrs. Al-Dana Khalid Al-Juffali has an indirect interest in it which is a medical insurance contract for the company’s employees for a year, for 13,417 SR. This agreement has no preferential terms.
Item (20): Approval on the business and contracts concluded between the company and Khalid Al-Juffali Company, in which a member of the Board of Directors Mrs. Al-Dana Khalid Al-Juffali has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 305,543 SR. This agreement has no preferential terms.
Item (21): Approval on business and contracts concluded between the company and Dahna International Marketing Company, in which a member of the Board of Directors Mrs. Dana Khalid Al-Juffali has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 25,725SR. This agreement has no preferential terms (Attached).
Page 3 of 4
Item (22): Approval on business and contracts concluded between the company and KHALID JUFFALI CONSTRUCTION CO., in which a member of the Board of Directors Mrs. Dana Khalid Al-Juffali has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 73,047SR. This agreement has no preferential term.
Item (23): Approval on business and contracts concluded between the company and KHALID JUFFALI INDUSTRIAL COMPANY, in which a member of the Board of Directors Mrs. Dana Khalid Al-Juffali has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 297,269 SR. This agreement has no preferential terms.
Item (24): Approval on business and contracts concluded between the company and AL-Dana KHALID JUFFALI COMPANY, in which a member of the Board of Directors Mrs. Dana Khalid Al-Juffali has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 2,633 SR. This agreement has no preferential terms.
Item (25): Approval on the business and contracts concluded between the company and the International Medical Center, in which a member of the Board of Directors Mr. Faisal Tamer has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 26,943,723 SR. This agreement has no preferential terms.
Item (26): Approval on business and contracts concluded between the company and the First Clinic in which a member of the Board of Directors Mr. Faisal Tamer has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year for 1,683,349 SR. This agreement has no preferential terms.
Item (27): Approval on works and contracts concluded between the company and the First X-rays in which a member of the Board of Directors Mr. Faisal Tamer has an indirect interest in it, which is a medical insurance contract for the company’s employees for a period of one year for 218,517 SR. This agreement has no preferential terms.
Item (28): Approval on business and contracts concluded between the company and the Akiyar International Company and for which a member of the Board of Directors Mr. Faisal Tamer has an indirect interest in it, which is a medical insurance contract for the company’s employees for a period of one year for 2,898,798 SR. This agreement has no preferential terms.
Item (29): Approval on business and contracts concluded between the company and a Tadawy company for which a member of the Board of Directors Mr. Faisal Tamer has an indirect interest in it, which is a medical insurance contract for the company’s employees for a period of one year for 86,574 SR. This agreement has no Preferential terms.
Item (30): Approval on business and contracts concluded between the company and Al-Huwaish Company, for which a member of the Board of Directors Mr. Faisal Tamer has an indirect interest in it, which is a medical insurance contract for the company’s employees for a period of one year for 1,195,650 SR. This agreement has no preferential terms.
Item (31): Approval on the business and contracts that will take place between the company and the Saudi Electronic Computer Company (SBM Ltd) in which a member of the Board of Directors Mrs. Dana Khalid Al-Juffali has an indirect interest in it which is a contract for providing computer equipment, licenses, and other things such as risk assessment & knowing that the business during The year 2020 amounted to 519 thousand SR. This agreement has no preferential terms.
Page 4 of 4
Item (32): Approval on the business and contracts that will take place between the company and Lonsdale and Associates Insurance Brokerage Company, in which a member of the Board of Directors Mrs. Dana Khalid Al- Juffali has an indirect interest in it which is a contract for providing insurance brokerage services, knowing that the business during the year 2020amounted to 58 thousand SR. This agreement has no preferential terms.
Item (33): Approval on the business and contracts that will take place between the company and the Suleiman Fakeeh Hospital Company and the Fakeeh Clinic, which a member of the board of directors Dr. Mazen Suleiman Fakeeh has an indirect interest in, which is a contract for providing health services to the insured, knowing that the business during the year 2020 amounted to 18,006,000million. This agreement has no preferential terms.
Item (34): Approval on the business and contracts that will take place between the company and the International Medical Hospital Company and for which a member of the Board of Directors Mr. Faisal Farouk Tamer has an indirect interest in it, which is a contract for providing health services to the insured, knowing that the business during the year 2020 amounted to 22,173,000SR. This agreement has no preferential terms.
Item (35): Approval on the business and contracts concluded between the company and Dr. Suleiman Fakeeh Hospital and for which as a member of the Board of Directors, Dr. Mazen Suleiman Abdel Qadir Fakeeh has an indirect interest in it, which is a medical insurance contract for the company’s employees for a year in the amount of 88,082SR and this agreement does not have any preferential conditions.
Item (36): Approval the appointment of the external auditors, Al-Azem & Partners-Crowe and El Sayed El- Ayouty & Partners – Moore International Ltd. from among the candidates based on the recommendation of the Board of Directors to examine, review, and audit the financial statement for the (second, third, fourth) quarters and annual for the fiscal year 2021 and first quarter of 2022 of the fiscal year and determine their fees.
Item (37): Approval on amending the remuneration policy for members of the Board of Directors, committees, and executive management.
